TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Phio Pharmaceuticals To Participate In The 3rd Annual Evercore ISI HealthCONx Conference

  • By PR Newswire
  • Nov 19, 2020 7:30 AM EST
PRESS RELEASES

Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer Treatment

  • By PR Newswire
  • Nov 9, 2020 8:00 AM EST
PRESS RELEASES

Phio Presents Additional Data Supporting Potential Of TIGIT Targeting INTASYL Compound In The Tumor Microenvironment At AACR 2020

  • By PR Newswire
  • Jun 22, 2020 9:00 AM EDT
PRESS RELEASES

Phio Presents Data On INTASYL As An Alternative To Genetic Modification To Improve Cell-based Immunotherapy At ASGCT 2020

  • By PR Newswire
  • May 14, 2020 4:05 PM EDT
PRESS RELEASES

Phio Pharmaceuticals And Helmholtz Zentrum München Announce Collaboration And Option Agreement With Medigene

  • By PR Newswire
  • Mar 10, 2020 5:06 PM EDT
PRESS RELEASES

Phio Pharmaceuticals Announces Closing Of $8.0 Million Underwritten Public Offering

  • By PR Newswire
  • Feb 13, 2020 5:20 PM EST
PRESS RELEASES

Phio Pharmaceuticals Announces Pricing Of $8.0 Million Underwritten Public Offering

  • By PR Newswire
  • Feb 11, 2020 9:15 AM EST
PRESS RELEASES

Phio Pharmaceuticals Announces Compliance With Nasdaq Listing Requirements

  • By PR Newswire
  • Feb 10, 2020 8:00 AM EST
PRESS RELEASES

Phio Pharmaceuticals Announces Closing Of $1.74 Million Registered Direct Offering Priced At-the-Market

  • By PR Newswire
  • Feb 6, 2020 12:30 PM EST
PRESS RELEASES

Phio Pharmaceuticals Announces $1.74 Million Registered Direct Offering Priced At-the-Market

  • By PR Newswire
  • Feb 5, 2020 9:00 AM EST
PRESS RELEASES

Phio Pharmaceuticals Announces Reverse Stock Split

  • By PR Newswire
  • Jan 14, 2020 12:55 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.